16 de enero de 2021
ÚLTIMAS NOTICIAS:
 1300x90
Hispanic World

Brazil: China vaccine's 50.38 pct. effectiveness can halt pandemic

Sao Paulo, Jan 12 (efe-epa).- The anti-Covid vaccine developed by China's Sinovac pharmaceutical laboratory and which will be used and produced in Brazil is able to halt the coronavirus pandemic despite the fact that its efficacy of only 50.38 percent is much below that achieved by other vaccines, top officials in charge of producing the drug in this country said Tuesday.

 photo taken Dec. 3, 2020, showing delivery at the Guarulhos International Airport in Sao Paulo, Brazil, of the first shipment of CoronaVac, an anti-Covid vaccine developed by China's Sinovac laboratory. EFE-EPA/Sebastiao Moreira/File

photo taken Dec. 3, 2020, showing delivery at the Guarulhos International Airport in Sao Paulo, Brazil, of the first shipment of CoronaVac, an anti-Covid vaccine developed by China's Sinovac laboratory. EFE-EPA/Sebastiao Moreira/File

Sao Paulo, Jan 12 (efe-epa).- The anti-Covid vaccine developed by China's Sinovac pharmaceutical laboratory and which will be used and produced in Brazil is able to halt the coronavirus pandemic despite the fact that its efficacy of only 50.38 percent is much below that achieved by other vaccines, top officials in charge of producing the drug in this country said Tuesday.

The Butantan Institute, tasked with developing and testing the vaccine in the South American giant along with Sinovac, and which will be responsible for manufacturing it in Brazil, said that despite its relatively low efficacy level compared with other vaccines, the drug was 100 effective in preventing serious Covid-19 cases requiring hospitalization.

"The study does not allow us to confirm that this vaccine will eradicate the disease, but (we can say) that it will be able to control the pandemic via the elevated reduction of hospitalizations," said the director of medical research at the Butantan Institute, Ricardo Palacios, at a press conference.

According to Palacios, none of the volunteers on whom the vaccine was tested and who contracted the disease needed hospitalization or developed a serious case of Covid-19.

A week after having reported that the vaccine had an efficacy rate of 78 percent in non-serious cases among patients who went to the doctor after showing symptoms of Covid-19, among the 12,508 volunteers who were given the drug in Brazil, the Institute said that the so-called global efficacy of the Sinovac vaccine was 50.38 percent.

The medical research organization said that the global efficacy rate is what indicates the ability of the vaccine to prevent Covid contagion, both in symptomatic and asymptomatic cases as well as in serious or mild cases and among people who either needed or did not need to go to the doctor.

The Institute added that both the World Health Organization and the National Health Monitoring Agency (Anvisa, Brazil's regulatory agency) consider a drug to be recommended for use when its global efficacy exceeds 50 percent.

When asked about the efficacy of more than 94 percent attained by other anti-Covid vaccines, such as the ones developed by Pfizer and Moderna, the Butantan officials said that those laboratories so far have not released all their studies while Sinovac has been completely transparent about the results achieved by its drug.

Although the Sinovac vaccine was developed with traditional techniques, which use the inactivated virus to spur the body to develop defenses against the live virus, the vaccines that have attained efficacy levels greater than 90 percent were developed with messenger-RNA modification techniques, which are considered to be the future of immunization.

According to the Butantan doctors, vaccines with efficacy rates of about 60 percent have shown themselves to able to control outbreaks of flu and tuberculosis and some with levels of 50 percent are able to halt epidemics of rotavirus and pertussis, or whooping cough.

"This vaccine is safe, effective and combines all the requirements that justify its being used under emergency conditions," said Butantan Institute director Dimas Covas.

He said that the global efficacy of the vaccine could be much greater than average in Brazil because it was tested in this country among health professionals, who are people in direct contact with the virus and with contagious patients.

He went on to say that if the vaccine would have been tested in Brazil in volunteers from other areas, probably results similar to those attained by CoronaVac in other countries would have been obtained.

In Indonesia, where its use has already been authorized, the efficacy of the Sinovac vaccine was 65.3 percent and in Turkey 91.25 percent.

"It's a very safe vaccine, which reduced the clinical disease in an extreme environment of high exposure. And that allows us to avoid the pressure of the pandemic on the health system. People will not need to go to hospitals because they don't develop the disease in its serious form," he said.

The Butantan Institute, which already has 10 million doses of the vaccine on hand, has authorization to manufacture it in Brazil, and the Brazilian Health Ministry has already announced an initial purchase of 100 million doses for its vaccination campaign.

These 100 million doses of the Sinovac vaccine are in addition to the 254 million doses of other vaccines that have been OK'd for use by Brazilian authorities for its immunization campaign.

Brazil is one of the worldwide epicenters of the Covid-19 pandemic and the country with the second-highest number of deaths from the disease after the US with about 204,000 fatalities. It is the No.3 country in terms of confirmed coronavirus cases with 8.13 million, following the US and India.

Histórico de noticias
Argentina promulgates law making abortions easier to get

By Javier Castro Bugarin

Miami Beach holding festival showcasing tropical "Art Deco" legacy

By Ana Mengotti

Last year ties 2016 as hottest year in recorded history

Miami, Jan 14 (efe-epa).- Last year tied 2016 as the hottest year since records have been kept, according to a report published Thursday by NASA that...

Organized crime in Mexico selling fake Covid-19 vaccines

By Cristina Sanchez Reyes

Trump asks supporters to avoid violence before inauguration

(Updates with Trump's 2nd video statement)

Trump losing business support, putting future of his brand in danger

By Mario Villar

US Justice Dept. to charge several hundred in mob that invaded Congress

Washington, Jan 12 (efe-epa).- The US Department of Justice on Tuesday announced that it already has formally charged more than 70 people with assorted...

Brazil: China vaccine's 50.38 pct. effectiveness can halt pandemic

Sao Paulo, Jan 12 (efe-epa).- The anti-Covid vaccine developed by China's Sinovac pharmaceutical laboratory and which will be used and produced in Brazil is...

Congress calls for Trump impeachment despite Pence rejection

Update 1: Reworks lede, changes headline, adds info on impeachment attempt

US puts Cuba back on list of terrorism sponsors

Washington, Jan 11 (efe-epa).- The Donald Trump administration on Monday put Cuba back on the US list of sponsors of terrorism, from which that country had...

Twitter suspends more than 70,000 accounts sharing QAnon content

Washington, Jan 12 (efe-epa).- Twitter announced that it has suspended more than 70,000 accounts dedicated to sharing QAnon content following the attack on...

Buenos Aires: Argentine equine serum effective, safe for Covid-19 cases

Buenos Aires, Jan 11 (efe-epa).- The hyperimmune serum produced from horses in Argentina completed the last phase of its clinical studies and "demonstrated...

International tourism in Mexico down 45.6 pct. year-on-year in November

Mexico City, Jan 11 (efe-epa).- Mexico hosted 45.6 percent fewer international tourists last November than during the same month in 2019, with arrivals...

Mexico begins 2021 with legislative, economic battles with businessmen

By Pedro Pablo Cortes

Clamor growing for Trump to resign, but president remaining silent

By Alfonso Fernandez

Health brigades disinfecting Mexican homes

By Cristina Sanchez Reyes

Authorities investigating death of Miami MD who got virus vaccine

Miami, Jan 7 (efe-epa).- The Miami-Dade County Medical Examiner's Office is investigating the death of obstetrician-gynecologist Gregory Michael, who died...

Biden taps judge Obama tried to put on Supreme Court for US attorney general

Washington, Jan 7 (efe-epa).- President-elect Joe Biden announced Thursday his pick for US attorney general in his upcoming administration federal Judge...

Honduras needs 350K workers to harvest coffee during peak of season

Tegucigalpa, Jan 7 (efe-epa).- Honduras needs some 350,000 people to work temporarily helping bring in the 2020-2021 coffee harvest, which has been reduced...

Elon Musk surpasses Jeff Bezos as world's richest person

New York, Jan 7 (efe-epa).- The founder and CEO of Tesla, Elon Musk, on Thursday surpassed Amazon boss Jeff Bezos as the world's richest person, according...

Gigantic vulva sculpture sparks controversy in Brazil

By Waldheim Garcia Montoya

Powerful in Americas following "stay home" orders by going on vacation

By Claudia Polanco Yermanos

Three Kings Day buying in Mexico only at 50 pct. due to pandemic

By Miquel Muñoz

Brazil finds factor upping chance of being infected with UK virus strain

Rio de Janeiro, Jan 5 (efe-epa).- A group of Brazilian researchers has identified one of the factors that increases the possibility of infection by the...